Lack of efficacy of dual intragastric balloon therapy on weight loss and patient dissatisfaction.
Document Type
Article
Publication Date
3-1-2021
Publication Title
American journal of surgery
Abstract
BACKGROUND: Dual intragastric balloon (DIGB) therapy is a non-surgical, restrictive method of weight loss. We evaluated weight loss and patient satisfaction after DIGB removal.
METHODS: Between 2016 and 2019, 35 patients had DIGB therapy. A retrospective review of weight loss at balloon removal and follow-up, adverse events during DIGB therapy, and patient satisfaction was performed.
RESULTS: At follow-up after balloon removal (22.3 ± 10.5 months), mean percent excess weight loss (%EWL) was significantly decreased compared to %EWL at removal (4.7 ± 42.7% vs 32.4 ± 38.8%, p = .001). Weight regain occurred in 22/31 (71%) patients. Adverse events during DIGB therapy included: nausea, abdominal pain, reflux, pancreatitis, and gastric outlet obstruction. Twenty-five (71.4%) patients completed a satisfaction questionnaire. Only 3/25 (12%) patients were satisfied, and 92% would not choose DIGB for weight loss.
CONCLUSION: Weight loss achieved from DIGB on average was not maintained after balloon removal. Most patients were not satisfied and would not choose DIGB again.
Volume
221
Issue
3
First Page
581
Last Page
584
Recommended Citation
Lew D, Thampy C, Hawasli A. Lack of efficacy of dual intragastric balloon therapy on weight loss and patient dissatisfaction. Am J Surg. 2021 Mar;221(3):581-584. doi: 10.1016/j.amjsurg.2020.11.010. Epub 2020 Nov 9. PMID: 33190789.
DOI
10.1016/j.amjsurg.2020.11.010
ISSN
1879-1883
PubMed ID
33190789
